130 related articles for article (PubMed ID: 37782190)
1. Metformin activates AMPK and mTOR to Inhibit RANKL-stimulated osteoclast formation.
Kim YS; Park BS; Baek HS; Kang HM; Oh JM; Kim IR
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8795-8811. PubMed ID: 37782190
[TBL] [Abstract][Full Text] [Related]
2. Suppression of AMP-activated protein kinase reverses osteoprotegerin-induced inhibition of osteoclast differentiation by reducing autophagy.
Tong X; Zhang C; Wang D; Song R; Ma Y; Cao Y; Zhao H; Bian J; Gu J; Liu Z
Cell Prolif; 2020 Jan; 53(1):e12714. PubMed ID: 31696568
[TBL] [Abstract][Full Text] [Related]
3. Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway.
Guo H; Ding D; Wang L; Yan J; Ma L; Jin Q
PLoS One; 2021; 16(12):e0261127. PubMed ID: 34914744
[TBL] [Abstract][Full Text] [Related]
4. High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway.
Cai ZY; Yang B; Shi YX; Zhang WL; Liu F; Zhao W; Yang MW
Biochem Biophys Res Commun; 2018 Sep; 503(2):428-435. PubMed ID: 29649480
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.
Jiang C; Wang Y; Zhang M; Xu J
Mol Biol Rep; 2022 Oct; 49(10):9217-9229. PubMed ID: 35881223
[TBL] [Abstract][Full Text] [Related]
6. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro.
Tong X; Gu J; Song R; Wang D; Sun Z; Sui C; Zhang C; Liu X; Bian J; Liu Z
J Cell Biochem; 2019 Feb; 120(2):1630-1642. PubMed ID: 30256440
[TBL] [Abstract][Full Text] [Related]
8. Metformin alleviates dexamethasone-induced apoptosis by regulating autophagy via AMPK/mTOR/p70S6K in osteoblasts.
Guo X; Liang M
Exp Cell Res; 2022 Jun; 415(1):113120. PubMed ID: 35341775
[TBL] [Abstract][Full Text] [Related]
9. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Meng S; Xian H; Che H; Lv J; Li Y; Yu Y; Bai Y; Wang L
Int J Biol Sci; 2019; 15(5):1010-1019. PubMed ID: 31182921
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.
Shi WY; Xiao D; Wang L; Dong LH; Yan ZX; Shen ZX; Chen SJ; Chen Y; Zhao WL
Cell Death Dis; 2012 Mar; 3(3):e275. PubMed ID: 22378068
[TBL] [Abstract][Full Text] [Related]
11. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
12. Metformin Promotes the Survival of Random-Pattern Skin Flaps by Inducing Autophagy via the AMPK-mTOR-TFEB signaling pathway.
Wu H; Ding J; Li S; Lin J; Jiang R; Lin C; Dai L; Xie C; Lin D; Xu H; Gao W; Zhou K
Int J Biol Sci; 2019; 15(2):325-340. PubMed ID: 30745824
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
Din FV; Valanciute A; Houde VP; Zibrova D; Green KA; Sakamoto K; Alessi DR; Dunlop MG
Gastroenterology; 2012 Jun; 142(7):1504-15.e3. PubMed ID: 22406476
[TBL] [Abstract][Full Text] [Related]
14. AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts.
Lee YS; Kim YS; Lee SY; Kim GH; Kim BJ; Lee SH; Lee KU; Kim GS; Kim SW; Koh JM
Bone; 2010 Nov; 47(5):926-37. PubMed ID: 20696287
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways.
Zamanian MY; Golmohammadi M; Yumashev A; Hjazi A; Toama MA; AbdRabou MA; Gehlot A; Alwaily ER; Shirsalimi N; Yadav PK; Moriasi G
Cell Biochem Funct; 2024 Jun; 42(4):e4071. PubMed ID: 38863255
[TBL] [Abstract][Full Text] [Related]
16. TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway.
Xu X; Gao H; Qin J; He L; Liu W
Int J Clin Exp Pathol; 2015; 8(9):10824-31. PubMed ID: 26617795
[TBL] [Abstract][Full Text] [Related]
17. Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms.
Chen SC; Brooks R; Houskeeper J; Bremner SK; Dunlop J; Viollet B; Logan PJ; Salt IP; Ahmed SF; Yarwood SJ
Mol Cell Endocrinol; 2017 Jan; 440():57-68. PubMed ID: 27856330
[TBL] [Abstract][Full Text] [Related]
18. Metformin Alleviates Sepsis-Associated Myocardial Injury by Enhancing AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Signaling Pathway-Mediated Autophagy.
Gao Y; Liu J; Li K; Li T; Li R; Zhang W; Zhang X; Wang Y; Chen M; Shi R; Cao J
J Cardiovasc Pharmacol; 2023 Oct; 82(4):308-317. PubMed ID: 37499052
[TBL] [Abstract][Full Text] [Related]
19. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
20. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
